GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gossamer Bio Inc (STU:4GB) » Definitions » Other Current Receivables

Gossamer Bio (STU:4GB) Other Current Receivables : €6.1 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Gossamer Bio Other Current Receivables?

Gossamer Bio's Other Current Receivables for the quarter that ended in Mar. 2025 was €6.1 Mil.

Gossamer Bio's quarterly Other Current Receivables declined from Sep. 2024 (€5.94 Mil) to Dec. 2024 (€5.10 Mil) but then increased from Dec. 2024 (€5.10 Mil) to Mar. 2025 (€6.09 Mil).

Gossamer Bio's annual Other Current Receivables stayed the same from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€0.00 Mil) but then increased from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€5.10 Mil).


Gossamer Bio Other Current Receivables Historical Data

The historical data trend for Gossamer Bio's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gossamer Bio Other Current Receivables Chart

Gossamer Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only - - - - 5.10

Gossamer Bio Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3.37 5.94 5.10 6.09

Gossamer Bio Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Gossamer Bio Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Gossamer Bio's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Gossamer Bio Business Description

Traded in Other Exchanges
Address
3115 Merryfield Row, Suite 120, San Diego, CA, USA, 92121
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio Headlines

No Headlines